» Articles » PMID: 22357219

Elimination of Rhodnius Prolixus in Central America

Overview
Journal Parasit Vectors
Publisher Biomed Central
Date 2012 Feb 24
PMID 22357219
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Rhodnius prolixus is one of the main vectors of Trypanosoma cruzi, causative agent of Chagas disease. In Central America, it was first discovered in 1915 in El Salvador, from where it spread northwest to Guatemala and Mexico, and southeast to Nicaragua and Costa Rica, arriving also in Honduras in the late 1950s. Indoor residual spraying (IRS) by the antimalaria services of Costa Rica prevented its spread southwards, and similar IRS programmes appear to have eliminated it from El Salvador by the late 1970s. In 1997, by resolution of the Ministers of Health of the seven Central American countries, a multinational initiative against Chagas disease (IPCA) was launched with one of the specific objectives being the elimination of R. prolixus from the region. As a result, more and more infested areas were encountered, and progressively sprayed using an IRS strategy already deployed against Triatoma infestans in the southern cone countries of South America. In 2008, Guatemala became the first of these countries to be formally certified as free of Chagas disease transmission due to R. prolixus. The other infested countries have since been similarly certified, and none of these has reported the presence of R. prolixus since June 2010. Further surveillance is required, but current evidence suggests that R. prolixus may now been eliminated from throughout the mesoamerican region, with a corresponding decline in the incidence of T. cruzi infections.

Citing Articles

New Approaches to the Ecology of in Peridomestic Environments of an Endemic Area of Minas Gerais, Brazil.

Valenca-Barbosa C, Andrade I, de Simas F, Neto O, Silva N, Costa C Pathogens. 2025; 14(2).

PMID: 40005553 PMC: 11858301. DOI: 10.3390/pathogens14020178.


The epidemiology of Chagas disease in the Americas.

Cucunuba Z, Gutierrez-Romero S, Ramirez J, Velasquez-Ortiz N, Ceccarelli S, Parra-Henao G Lancet Reg Health Am. 2024; 37:100881.

PMID: 39474465 PMC: 11519694. DOI: 10.1016/j.lana.2024.100881.


Genome report: First whole genome sequence of (Le Conte, 1855), vector of Chagas disease.

Peterson J, MacDonald M, Ellis V bioRxiv. 2024; .

PMID: 39416058 PMC: 11482757. DOI: 10.1101/2024.10.07.611472.


Interaction of , Triatomines and the Microbiota of the Vectors-A Review.

Schaub G Microorganisms. 2024; 12(5).

PMID: 38792688 PMC: 11123833. DOI: 10.3390/microorganisms12050855.


Chagas disease in immunocompromised patients.

Clark E, Messenger L, Whitman J, Bern C Clin Microbiol Rev. 2024; 37(2):e0009923.

PMID: 38546225 PMC: 11237761. DOI: 10.1128/cmr.00099-23.


References
1.
Ibanez-Bernal S . [Natural Trypanosoma cruzi infection of Triatominae bugs associated with human habitations in Mexico ]. Salud Publica Mex. 2001; 42(6):496-503. View

2.
Paz-Bailey G, Monroy C, Rodas A, Rosales R, Tabaru R, Davies C . Incidence of Trypanosoma cruzi infection in two Guatemalan communities. Trans R Soc Trop Med Hyg. 2002; 96(1):48-52. DOI: 10.1016/s0035-9203(02)90236-1. View

3.
Dias E . [Chagas' disease in the Americas. IV. Bolivia and Paraguay]. Rev Bras Malariol Doencas Trop. 1953; 5(1):11-6. View

4.
Guillen G, Diaz R, Jemio A, Cassab J, Pinto C, Schofield C . Chagas disease vector control in Tupiza, southern Bolivia. Mem Inst Oswaldo Cruz. 1997; 92(1):1-8. DOI: 10.1590/s0074-02761997000100001. View

5.
Gamboa J . [Survey of extra-domiciliary Rhodnius prolixus in Venezuela. (Preliminary report)]. Bol Oficina Sanit Panam. 1963; 54:18-25. View